ArticleHemaSphere2025

Chimeric antigen receptor T-cell therapy in diffuse large B-cell lymphoma: Evaluating axicabtagene ciloleucel in the ZUMA-7 trial.

Vadim Lesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.